Fluorescent microscopy finds lung cancer cells in Biomoda study

Cancer diagnostics company Biomoda (Albuquerque, NM) launched a pilot clinical study of its CyPath diagnostic assay, which is based on a porphyrin compound that binds to cancer cells and fluoresces under specific frequencies of light.  Participants in the pilot clinical study provide deep-lung sputum samples to be labeled with the CyPath solution and viewed under fluorescent microscopy.

Waterbury Pulmonary Associates Research (Waterbury, CT) has joined the pilot clinical study and is enrolling participants for the positive control group—patients diagnosed with lung cancer who have not yet started treatment. The company is the clinical research arm of a pulmonary and critical care practice.

“The addition of Waterbury Pulmonary as an enrollment site for the positive control group should expedite patient recruitment and the completion of our pilot study,” Biomoda Chief Executive Officer Maria Zannes said.  “Completing the pilot study is our top priority.”

Dr. David G. Hill, director of clinical research at Waterbury Pulmonary, will serve as the local Principal Investigator (PI) for Biomoda’s study.  Board-certified in critical care, pulmonary and internal medicine, Dr. Hill is also affiliated with the Yale University School of Medicine and its teaching hospitals. The protocol for Waterbury Pulmonary’s participation in the Biomoda study was approved by the Biomedical Research Alliance of New York (BRANY; www.brany.com) Institutional Review Board.

Dr. Thomas L. Bauer, national PI of the Biomoda study, will continue to oversee collection of samples in the positive control group at the Helen F. Graham Cancer Center, Christiana Care Health System, in Newark, DE, where he is chief of thoracic surgery.

Biomoda is seeking FDA approval of its screening technology as a Class III medical device.  Pending FDA approval, CyPath is for investigational use only.

Source: Biomoda


Posted by Lee Mather

Follow us on Twitter

Follow OptoIQ on your iPhone; download the free app here.

Subscribe now to BioOptics World magazine; it's free!

Get All the BioOptics World News Delivered to Your Inbox

Subscribe to BioOptics World Magazine or email newsletter today at no cost and receive the latest news and information.

 Subscribe Now
Related Articles

New bioimaging technique offers clear view of nervous system

Scientists at Ludwig-Maximilians University have developed a technique for turning the body of a deceased rodent entirely transparent, revealing the central nervous system in unprecedented clarity....

Fluorescent jellyfish proteins light up unconventional laser

Safer lasers to map your cells could soon be in the offing -- all thanks to the humble jellyfish. Conventional lasers, like the pointer you might use to entertain your cat, produce light by emittin...

Fluorescence microscopy helps provide new insight into how cancer cells metastasize

By using fluorescence microscopy, scientists have discovered an alternate theory on how some cancer cells metastasize.

In vivo imaging method visualizes bone-resorbing cell function in real time

In vivo imaging can visualize sites where osteoclasts (bone-resorbing cells) were in the process of resorbing bone.


Neuro15 exhibitors meet exacting demands: Part 2

Increasingly, neuroscientists are working with researchers in disciplines such as chemistry and p...

Why be free?

A successful career contributed to keeping OpticalRayTracer—an optical design software program—fr...

LASER Munich 2015 is bio-bent

LASER World of Photonics 2015 included the European Conferences on Biomedical Optics among its si...

White Papers

Understanding Optical Filters

Optical filters can be used to attenuate or enhance an image, transmit or reflect specific wavele...

How can I find the right digital camera for my microscopy application?

Nowadays, image processing is found in a wide range of optical microscopy applications. Examples ...



Twitter- BioOptics World

Copyright © 2007-2016. PennWell Corporation, Tulsa, OK. All Rights Reserved.PRIVACY POLICY | TERMS AND CONDITIONS